We look in detail at the state of marking recently-private-fintechs to the public market in mid-2021. Multiple industry segments have seen IPOs, direct listings, and SPACs transition fintech darlings into traditional stocks. How is performance doing? Is everything as magnificent and rich as we expected? Have multiples and valuations fallen or held steady? The analysis explores the answers and provides an explanatory framework.
ZhongAn starts trading tomorrow and raised $1.5bn last week, valuing the group at up to $10bn; the IPO has begun pushing insurtech into the mainstream as the company has seen growing interest across the world; the use of AI & big data have been driving forces behind the company and a main reason for investor interest; this might help to give momentum to other insurtech firms like Lemonade and Oscar. Source.